Presenting the top 5 startups from the first #AMR Challenge for 2024 by @SBI_Foundation & C-CAMP. #UltraNutri - Alternative proteins derived from insects for the development of shrimp feed #Vitulomics - A phyto-therapeutic topical solution for clinical mastitis. @HaystackLab - Genome sequencing-based test for diagnosis of neonatal sepsis @SpotSense - Non-invasive neonatal sepsis screening and monitoring tool #HealSeq - A new diagnostic test to guide an evidence-based approach to the management of neonatal sepsis The #AMR Challenge offers: 📌Upto INR 50 lakh investment opportunity, 📌Networking Mentorship with Indian and global experts 📌Opportunity for validation studies, commercialization and deployment 📌Technology showcase opportunity Congratulations! 🎉#IndiaFightsAMR #InnovatorsforBharat @PrinSciAdvOff @Taslimarif @DBTIndia @BIRAC_2012 @NITIAayog @ICMRDELHI @CARB_X @BMGFIndia @FINDdx @ICARS_global @gardp_amr @AMRActionFund @BARDA @ITBTGoK

The SBIF-CCAMP first India #AMR Challenge 2024 was launched on Dec 28th, 2023. We had a nation-wide search for solutions in *AMR in Human Health *AMR in One Health *Late-stage Innovations in AMR 2.5 months later we selected our top 5 from a pool of 100 applications with solutions across one health including aquaculture, dairy industry, and neonatal sepsis. Dr @Taslimarif, Dir-CEO C-CAMP said: "Through this programme we will support selected innovators in tackling AMR, emphasising C-CAMP's ongoing efforts to address this global challenge, through problem-solving, resource-building and mentorship. AMR is a global challenge with widespread market issues that need addressing. We are grateful for the support from the SBI Foundation, which began during the COVID-19 pandemic. This new joint programme aims to foster deep science components at different readiness levels." Mr. Sanjay Prakash, MD and CEO of @SBI_Foundation added, "It has been a long and rigorous selection process. From the initial 108 applications, we narrowed it down to 5 and prioritised high quality throughout the selection. As a layperson, the concept of AMR was entirely new to me. However, my first visit to C-CAMP gave me insight into the new field. We are excited about this collaboration with CCAMP, which has expertise in deep science and innovation research, with advanced state-of-the-art facilities." Here are a few glimpses from the announcement ceremony at CCAMP - #IndiaFightsAMR #InnovatorsforBharat @SukrityAmrita @spotsense #healseq @HaystackLab #Ultranutri @nitsathy #Vitulomics

IHF is proud to support the development of Healseq's breakthrough DR TB diagnostic test. This innovation is a valuable addition in our efforts to invest in science-led innovations that hold the potential to create equitable healthcare solutions against deadly diseases like TB.

Introducing Healseq: We aim to transform healthcare with advanced prognostic, diagnostic and discovery platforms, offering affordable and innovative precision solutions to improve patient outcomes. Explore more about us at Healseq Website!